What are the predictors of 90-day mortality in patients undergoing primary shoulder arthroplasty?
90-day mortality after primary shoulder arthroplasty is generally low, but risk is significantly influenced by baseline comorbidities, ASA class, and underlying tumor diagnosis.
90-day mortality following shoulder arthroplasty was low. An underlying diagnosis of tumor, higher comorbidity and higher ASA class were risk factors for higher 90-day mortality, while higher BMI was protective. Pre-operative comorbidity management may impact 90-day mortality following shoulder arthroplasty. A higher unadjusted mortality in patients undergoing TSA versus HHR may indicate the underlying differences in patients undergoing these procedures.
Singh et al. (Wed,) studied this question.